Published in J Antimicrob Chemother on January 01, 1999
Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol (1999) 2.33
Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan. Emerg Infect Dis (2004) 1.94
Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerg Infect Dis (2001) 1.78
A between-species comparison of antimicrobial resistance in enterobacteria in fecal flora. Antimicrob Agents Chemother (2000) 1.33
Life-threatening infantile diarrhea from fluoroquinolone-resistant Salmonella enterica typhimurium with mutations in both gyrA and parC. Emerg Infect Dis (2003) 1.32
New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility. J Clin Microbiol (2005) 1.11
Impact of feed supplementation with antimicrobial agents on growth performance of broiler chickens, Clostridium perfringens and enterococcus counts, and antibiotic resistance phenotypes and distribution of antimicrobial resistance determinants in Escherichia coli isolates. Appl Environ Microbiol (2007) 1.10
Genotypic analysis of Escherichia coli strains from poultry carcasses and their susceptibilities to antimicrobial agents. Appl Environ Microbiol (2001) 0.96
Increasing prevalence of quinolone resistance in human nontyphoid Salmonella enterica isolates obtained in Spain from 1981 to 2003. Antimicrob Agents Chemother (2004) 0.96
Trends in antimicrobial resistance phenotypes in non-typhoid Salmonellae from human and poultry origins in France. Epidemiol Infect (2006) 0.96
Antimicrobial resistance among Salmonella and Shigella isolates in five Canadian provinces (1997 to 2000). Can J Infect Dis Med Microbiol (2006) 0.84
In vitro activities of 11 fluoroquinolones against 816 non-typhoidal strains of Salmonella enterica isolated from Finnish patients with special reference to reduced ciprofloxacin susceptibility. Ann Clin Microbiol Antimicrob (2005) 0.78
The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med (1997) 9.63
Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother (1993) 4.83
Antimicrobial resistance. Is a major threat to public health. BMJ (1998) 4.18
A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother (1998) 3.97
P-fimbriated clones among uropathogenic Escherichia coli strains. Infect Immun (1984) 3.50
Mannose-resistant haemagglutination and P antigen recognition are characteristic of Escherichia coli causing primary pyelonephritis. Lancet (1982) 3.39
An international outbreak of Salmonella infections caused by alfalfa sprouts grown from contaminated seeds. J Infect Dis (1997) 3.39
Direct amplification of rRNA genes in diagnosis of bacterial infections. J Clin Microbiol (2000) 3.02
Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance. Antimicrob Agents Chemother (1999) 2.73
Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Arch Intern Med (2000) 2.37
Different erythromycin resistance mechanisms in group C and group G streptococci. Antimicrob Agents Chemother (1998) 2.33
Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol (1999) 2.33
Parainfluenza virus type 3 infections in a hematology unit. Bone Marrow Transplant (2001) 2.17
Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis (1996) 2.15
Molecular epidemiology of an outbreak of febrile gastroenteritis caused by Listeria monocytogenes in cold-smoked rainbow trout. J Clin Microbiol (1999) 2.11
Use of the polymerase chain reaction and DNA sequencing for detection of Bartonella quintana in the aortic valve of a patient with culture-negative infective endocarditis. Clin Infect Dis (1995) 2.07
Etiology of aseptic meningitis and encephalitis in an adult population. Neurology (2006) 1.90
Quantitative differences in adhesiveness of type 1 fimbriated Escherichia coli due to structural differences in fimH genes. J Bacteriol (1995) 1.82
Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine. Lancet (1991) 1.82
katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients. Antimicrob Agents Chemother (1996) 1.82
Clinical isolates of non-O157 Shiga toxin-producing Escherichia coli: serotypes, virulence characteristics, and molecular profiles of strains of the same serotype. J Clin Microbiol (2001) 1.81
Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerg Infect Dis (2001) 1.78
Evaluation of methods for epidemiologic typing of group A streptococci. J Infect Dis (1994) 1.75
Outbreak of diarrhoea due to Escherichia coli O111:B4 in schoolchildren and adults: association of Vi antigen-like reactivity. Lancet (1990) 1.65
Typing of group A streptococci by random amplified polymorphic DNA analysis. J Clin Microbiol (1994) 1.63
Protein C substitution in sepsis-associated purpura fulminans. Crit Care Med (2000) 1.60
Recurrent urinary tract infections in infancy: relapses or reinfections? J Infect Dis (2002) 1.54
Salmonella in alfalfa sprouts. Lancet (1995) 1.52
A novel dihydrofolate reductase cassette inserted in an integron borne on a Tn21-like element. Antimicrob Agents Chemother (1993) 1.51
Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. J Infect Dis (1997) 1.50
Control of antimicrobial resistance: time for action. The essentials of control are already well known. BMJ (1998) 1.48
Antibiotic resistance. How wild are wild mammals? Nature (2001) 1.48
Guideline for the management of acute sore throat. Clin Microbiol Infect (2012) 1.48
Expression of P, type-1, and type-1C fimbriae of Escherichia coli in the urine of patients with acute urinary tract infection. J Infect Dis (1987) 1.44
Protein C in the treatment of coagulopathy in meningococcal disease. Crit Care Med (1998) 1.44
Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin Infect Dis (1995) 1.43
In vitro activity of a new cyclic lipopeptide antibiotic, LY146032, against gram-positive clinical bacteria. Antimicrob Agents Chemother (1987) 1.41
Shiga toxin-producing Escherichia coli in finland from 1990 through 1997: prevalence and characteristics of isolates. J Clin Microbiol (1998) 1.39
Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology (Oxford) (2002) 1.38
Effect of transport medium on recovery of Aeromonas species in intestinal infections. Eur J Clin Microbiol Infect Dis (1990) 1.38
Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance. J Infect Dis (1998) 1.36
matB, a common fimbrillin gene of Escherichia coli, expressed in a genetically conserved, virulent clonal group. J Bacteriol (2001) 1.35
Evaluation of five different methods to prepare bacterial extracts for the identification of beta-lactamases by isoelectric focusing. J Antimicrob Chemother (1993) 1.34
A between-species comparison of antimicrobial resistance in enterobacteria in fecal flora. Antimicrob Agents Chemother (2000) 1.33
Ribotyping as an epidemiologic tool for Escherichia coli. Epidemiol Infect (1994) 1.30
Increase of trimethoprim resistance among Shigella species, 1975-1988: analysis of resistance mechanisms. J Infect Dis (1990) 1.29
Bacteriology of histopathologically defined appendicitis in children. Pediatr Infect Dis J (2000) 1.28
Application of gas-liquid chromatographic analysis of cellular fatty acids for species identification and typing of coagulase-negative staphylococci. J Clin Microbiol (1991) 1.27
In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species. Antimicrob Agents Chemother (2001) 1.27
An outbreak of Listeria monocytogenes serotype 3a infections from butter in Finland. J Infect Dis (2000) 1.27
Multiple outbreaks of Yersinia pseudotuberculosis infections in Finland. J Clin Microbiol (2004) 1.26
Fimbriation, capsulation, and iron-scavenging systems of Klebsiella strains associated with human urinary tract infection. Infect Immun (1992) 1.25
Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. Clin Infect Dis (1995) 1.22
Seasonal variation in etiology of travelers' diarrhea. Finnish-Moroccan Study Group. J Infect Dis (1992) 1.22
Survey of condition-based prescribing of antimicrobial drugs for dogs at a veterinary teaching hospital. Vet Rec (2004) 1.21
Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice. Diabetologia (2011) 1.20
Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. J Infect Dis (1990) 1.20
Epidemiology of plasmid-mediated beta-lactamases in enterobacteria Swedish neonatal wards and relation to antimicrobial therapy. Antimicrob Agents Chemother (1992) 1.20
Distribution of molecular subtypes within Salmonella enterica serotype Enteritidis phage type 4 and S. Typhimurium definitive phage type 104 in nine European countries, 2000-2004: results of an international multi-centre study. Epidemiol Infect (2006) 1.20
Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents. Clin Infect Dis (2001) 1.19
Erythromycin resistance genes in group A streptococci of different geographical origins. The Macrolide Resistance Study Group. J Antimicrob Chemother (2000) 1.19
Oat beta-glucan and xylan hydrolysates as selective substrates for Bifidobacterium and Lactobacillus strains. Appl Microbiol Biotechnol (1998) 1.19
Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Finland. Eur J Clin Microbiol Infect Dis (2000) 1.19
Reactive arthritis following an outbreak of Salmonella infection in Finland. Br J Rheumatol (1994) 1.19
Association of Aeromonas spp. with travellers' diarrhoea in Finland. J Med Microbiol (1995) 1.18
Molecular and phenotypic profiling of sorbitol-fermenting Escherichia coli O157:H- human isolates from Finland. Clin Microbiol Infect (2006) 1.18
Antimicrobial susceptibility of Enterobacteriaceae isolated from vegetables. J Antimicrob Chemother (1999) 1.17
Infective endocarditis in a Finnish teaching hospital: a study on 326 episodes treated during 1980-2004. Heart (2006) 1.17
Trimethoprim resistance in Finland after five years' use of plain trimethoprim. Br Med J (1980) 1.16
Characterization of Hafnia alvei by biochemical tests, random amplified polymorphic DNA PCR, and partial sequencing of 16S rRNA gene. J Clin Microbiol (1995) 1.15
Salmonella enteritidis phage types 1 and 4: pheno- and genotypic epidemiology of recent outbreaks in Finland. J Clin Microbiol (1999) 1.15
Short-term treatment of traveler's diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons. Clin Infect Dis (1993) 1.15
Pneumonia in childhood: etiology and response to antimicrobial therapy. Eur J Clin Microbiol Infect Dis (1992) 1.14
Distribution of Aeromonas phenospecies and genospecies among strains isolated from water, foods or from human clinical samples. Epidemiol Infect (1995) 1.11
Four fatal cases of nephropathia epidemica. Scand J Infect Dis (1995) 1.10
Characterization of trimethoprim resistance by use of probes specific for transposon Tn7. Antimicrob Agents Chemother (1984) 1.10
New 16-plex PCR method for rapid detection of diarrheagenic Escherichia coli directly from stool samples. Eur J Clin Microbiol Infect Dis (2009) 1.09
Hafnia alvei in stool specimens from patients with diarrhea and healthy controls. J Clin Microbiol (1994) 1.08
Reactive arthritis attributable to Shigella infection: a clinical and epidemiological nationwide study. Ann Rheum Dis (2004) 1.07
Rapid detection of rifampin-resistant Mycobacterium tuberculosis by sequencing and line probe assay. Scand J Infect Dis (1998) 1.07
Surveillance of listeriosis in Finland during 1995-2004. Euro Surveill (2006) 1.06
Analysis of genetic localization of the type I trimethoprim resistance gene from Escherichia coli isolated in Finland. Antimicrob Agents Chemother (1991) 1.06
In vitro susceptibility of Streptococcus mutans to chlorhexidine and six other antimicrobial agents. Antimicrob Agents Chemother (1993) 1.06
Molecular epidemiology of an outbreak caused by Salmonella enterica serovar Newport in Finland and the United Kingdom. Epidemiol Infect (2000) 1.05
Yersinia pseudotuberculosis causing a large outbreak associated with carrots in Finland, 2006. Epidemiol Infect (2009) 1.05
Aminoglycoside resistance among blood culture isolates. J Clin Microbiol (1984) 1.05
Swimming-associated outbreak of Escherichia coli O157:H7. Epidemiol Infect (1999) 1.04
Bacteriotherapy: the time has come. BMJ (2001) 1.03
Molecular epidemiology of two international sprout-borne Salmonella outbreaks. J Clin Microbiol (1997) 1.02
Relationship of pulsed-field profiles with key phage types of Salmonella enterica serotype Enteritidis in Europe: results of an international multi-centre study. Epidemiol Infect (2007) 1.02
The role of pili in the adhesion of Escherichia coli to human urinary tract epithelial cells. Scand J Infect Dis Suppl (1982) 1.01